We are live on ! Find out more
FNBT

FineMark National Bank & Trust Portfolio holdings

AUM $3.2B
1-Year Est. Return 18.28%
This Fund
S&P 500
This Quarter Est. Return
-3.85%
1 Year Est. Return
+18.28%
3 Year Est. Return
+69.81%
5 Year Est. Return
+87.67%
10 Year Est. Return
+274.39%
AUM
$2.3B
AUM Growth
-$135M
Cap. Flow
-$26.3M
Cap. Flow %
-1.14%
Top 10 Hldgs %
37.6%
Holding
445
New
14
Increased
103
Reduced
220
Closed
28

Top Sells

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$5.55M
2
BDX icon
Becton Dickinson
BDX
+$5.39M
3
LHX icon
L3Harris
LHX
+$5.35M
4
AVTR icon
Avantor
AVTR
+$3.8M
5
UNP icon
Union Pacific
UNP
+$3.32M

Sector Composition

Rank Sector Weight
1 Industrials 19.2%
2 Technology 15.89%
3 Financials 8.4%
4 Healthcare 8.32%
5 Consumer Discretionary 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPSM icon
401
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.5B
-6,664
Closed -$259K
TTD icon
402
Trade Desk
TTD
$6.34B
-3,592
Closed -$277K
VCIT icon
403
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$67.6B
-2,769
Closed -$219K
VDE icon
404
Vanguard Energy ETF
VDE
$10.4B
-2,300
Closed -$260K
VRTX icon
405
Vertex Pharmaceuticals
VRTX
$133B
-845
Closed -$297K
MMP
406
DELISTED
Magellan Midstream Partners, L.P.
MMP
-3,426
Closed -$214K

Similar funds

FineMark National Bank & Trust's Q3 2023 Portfolio in Review

As of Q3 2023, FineMark National Bank & Trust held 445 positions worth $2.3B, down 5.5% from $2.43B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

FineMark National Bank & Trust's Q3 2023 filing shows 14 new, 103 increased, 220 reduced and 28 closed positions. Its largest new stake was Marsh: 16,517 shares worth $3.14M. The largest sale was CVS Health, an estimated $5.55M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 21% a quarter earlier, followed by Technology and Financials.

  • FineMark National Bank & Trust's largest Q3 2023 buy was Marsh: 16,517 shares worth $3.14M.
  • FineMark National Bank & Trust added most to Thermo Fisher Scientific in Q3 2023, an estimated $8.61M increase.
  • FineMark National Bank & Trust's biggest Q3 2023 reduction was CVS Health, cutting an estimated $5.55M.
  • FineMark National Bank & Trust fully exited Align Technology in Q3 2023, selling an estimated $461K.
  • FineMark National Bank & Trust's ten largest holdings make up 38% of its $2.3B portfolio in Q3 2023.
  • FineMark National Bank & Trust opened 14 new positions and closed 28 in Q3 2023.
  • FineMark National Bank & Trust's portfolio value fell 5.5% quarter-over-quarter to $2.3B.

Based on FineMark National Bank & Trust's 13F filing for Q3 2023, filed 13 Nov 2023.